{"data":[{"accessionNo":"0001738048-26-000077","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001806540","issuerName":"Lycia Therapeutics, Inc.","ticker":"LYCA","cusip":"55081P100","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-10-23","reportingPerson":"Nimish Shah","reportingCik":null,"personType":"IN","sharesOwned":6850237,"percentOfClass":11.9,"filedAt":"2026-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/lyca"},{"accessionNo":"0001738048-26-000077","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001806540","issuerName":"Lycia Therapeutics, Inc.","ticker":"LYCA","cusip":"55081P100","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-10-23","reportingPerson":"Bong Y. Koh","reportingCik":null,"personType":"IN","sharesOwned":6850237,"percentOfClass":11.9,"filedAt":"2026-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/lyca"},{"accessionNo":"0001738048-26-000077","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001806540","issuerName":"Lycia Therapeutics, Inc.","ticker":"LYCA","cusip":"55081P100","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-10-23","reportingPerson":"VHCP Management XP, LLC","reportingCik":null,"personType":"OO","sharesOwned":6850237,"percentOfClass":11.9,"filedAt":"2026-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/lyca"},{"accessionNo":"0001738048-26-000077","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001806540","issuerName":"Lycia Therapeutics, Inc.","ticker":"LYCA","cusip":"55081P100","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-10-23","reportingPerson":"Venrock Healthcare Capital Partners XP, L.P.","reportingCik":null,"personType":"PN","sharesOwned":6850237,"percentOfClass":11.9,"filedAt":"2026-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/lyca"},{"accessionNo":"0001738048-26-000077","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001806540","issuerName":"Lycia Therapeutics, Inc.","ticker":"LYCA","cusip":"55081P100","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-10-23","reportingPerson":"VHCP Management EG, LLC","reportingCik":null,"personType":"OO","sharesOwned":6850237,"percentOfClass":11.9,"filedAt":"2026-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/lyca"},{"accessionNo":"0001738048-26-000077","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001806540","issuerName":"Lycia Therapeutics, Inc.","ticker":"LYCA","cusip":"55081P100","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-10-23","reportingPerson":"VHCP Management III, LLC","reportingCik":null,"personType":"OO","sharesOwned":6850237,"percentOfClass":11.9,"filedAt":"2026-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/lyca"},{"accessionNo":"0001738048-26-000077","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001806540","issuerName":"Lycia Therapeutics, Inc.","ticker":"LYCA","cusip":"55081P100","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-10-23","reportingPerson":"Venrock Healthcare Capital Partners EG, L.P.","reportingCik":null,"personType":"PN","sharesOwned":6850237,"percentOfClass":11.9,"filedAt":"2026-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/lyca"},{"accessionNo":"0001738048-26-000077","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001806540","issuerName":"Lycia Therapeutics, Inc.","ticker":"LYCA","cusip":"55081P100","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-10-23","reportingPerson":"VHCP Co-Investment Holdings III, LLC","reportingCik":null,"personType":"OO","sharesOwned":6850237,"percentOfClass":11.9,"filedAt":"2026-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/lyca"},{"accessionNo":"0001738048-26-000077","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001806540","issuerName":"Lycia Therapeutics, Inc.","ticker":"LYCA","cusip":"55081P100","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-10-23","reportingPerson":"Venrock Healthcare Capital Partners III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":6850237,"percentOfClass":11.9,"filedAt":"2026-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/lyca"}],"updatedAt":"2026-11-04T08:32:45.661Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/lyca","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}